期刊文献+

高效液相色谱法测定氟伐他汀钠缓释片的有关物质 被引量:1

Determination of Related Substances in Fluvastatin Sodium Extended-release Tablets by HPLC
下载PDF
导出
摘要 目的 建立氟伐他汀钠缓释片有关物质的高效液相色谱(HPLC)测定方法,为建立氟伐他汀钠缓释片的质量控制标准提供参考。方法 色谱柱为ZORBAX Eclipse Plus C18Rapid Resolution(75 mm×4.6 mm, 3.5μm);流动相A:pH值7.2缓冲液-甲醇乙腈混合液(体积比90:10),流动相B:pH值7.2缓冲液-甲醇乙腈混合液(体积比10:90),梯度洗脱;流速:2.0 mL·min^(-1);柱温:35℃;检测波长:305,365 nm;进样量:25μL。结果 主峰与各杂质峰均能达到完全分离;杂质A、B、C、D、E、F、G的检测限分别是0.069 5,0.032 5,0.059 3,0.074 0,0.050 3,0.048 6,0.026 3μg·mL^(-1),杂质A、B、C、D、E、F、G的定量限分别是0.2318,0.108 3,0.197 8,0.246 6,0.167 6,0.162 1,0.087 6μg·mL^(-1);在研究的浓度范围内与各自峰面积呈良好的线性关系,杂质A、B、C、D、E、F、G的线性浓度范围分别是0.231 8~6.0,0.108 3~1.2,0.197 8~1.2,0.246 6~3.0,0.167 6~1.2,0.162 1~3.0,0.087 6~1.2μg·mL^(-1);回收率89.8%~103.5%;供试品溶液在5℃中保存54 h稳定。结论 该方法简单、准确、可靠,能满足氟伐他汀钠缓释片有关物质的检测要求。 Objective To establish an HPLC method for determining related substances in fluvastatin sodium extended-release tablets and provide a basis for the specification of fluvastatin sodium extended-release tablets.Methods The analyte was gradient eluted on a C 18 column(ZORBAX Eclipse Plus C 18 Rapid Resolution,75 mm×4.6 mm,3.5μm)with mobile phase A pH 7.2 buffer and methanol-acetonitrile mixture(the volume ratio is 90:10)and mobile phase B pH 7.2 buffer and methanol-acetonitrile mixture(the volume ratio is 10:90).The flow rate was 2.0 mL·min^(-1).The column temperature was set at 35℃.The detective wavelengths were 305 nm and 365 nm,and the injection volume was 25μL.Results The impurity peaks were completely separated from the principal component peak.The detection limits for impurities A,B,C,D,E,F,and G were 0.0695,0.0325,0.0593,0.0740,0.0503,0.0486,and 0.0263μg·mL^(-1),respectively.The quantitation limits for impurities A,B,C,D,E,F,and G were 0.2318,0.1083,0.1978,0.2466,0.1676,0.1621 and 0.0876μg·mL^(-1) respectively.There was a good linear relationship between the concentration and peak area within the concentration range of the study,and the linearity concentration ranges of impurities A,B,C,D,E,F,and G were 0.2318-6.0,0.1083^(-1).2,0.1978^(-1).2,0.2466-3.0,0.1676^(-1).2,0.1621-3.0,0.0876^(-1).2μg·mL^(-1) respectively.The recovery was 89.8%^(-1)03.5%.The sample solution was stable in 54 h at 5℃.Conclusion The method is simple,accurate,and reliable for determining related substances in fluvastatin sodium extended-release tablets.
作者 赵海涛 张振 王胜民 王东凯 ZHAO Haitao;ZHANG Zhen;WANG Shengmin;WANG Dongkai(School of Pharmacy,Shenyang Pharmaceutical University,Shenyang,110016,China;Beijing Sciecure Pharmaceutical Co.,Ltd,Beijing 101300,China)
出处 《医药导报》 CAS 北大核心 2023年第5期712-717,共6页 Herald of Medicine
关键词 氟伐他汀钠缓释片 有关物质 含量测定 高效液相色谱法 Fluvastatin sodium extended-release tablets Related substances Content determination High performance liquid chromatography
  • 相关文献

参考文献9

二级参考文献53

  • 1周鹏,朱大龙,叶尔肯,陈南衡,西琳,张燕.控制高甘油三酯血症对胰岛素抵抗和糖代谢影响的五年前瞻性研究[J].中华糖尿病杂志(1006-6187),2005,13(6):418-420. 被引量:11
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3于丽达 尹风玲 张志华 等.氟伐他汀钠调节血脂的临床观察.滨州医学院学报,2007,30(1):19-21.
  • 4王新德.神经系统血管性疾病[M].北京:人民军医出版社,2006.532.
  • 5韩仲岩.实用脑血管病学[M].上海:上海科学技术出版社,2008.91.
  • 6芮德源.脑血管疾病的基础与临床[M].哈尔滨:黑龙江人民出版社,2005:587-589.
  • 7慕容洋洋,江山,苏宁.氟伐他汀治疗高脂血症的疗效分析与前瞻性研究[J].中华内科杂志,2013,42(1):31-33.
  • 8陈修.心血管药理学[M].北京:人民卫生出版社,2005:66-70.
  • 9史玉泉.实用神经病学[M].上海:上海科学技术出版社,2006:505-508.
  • 10龙爱英,吕艳荣,马成.氟伐他汀治疗高脂血症的疗效分析与进展性研究[J].中国神经疾病杂志,2013,39(1):163-166.

共引文献25

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部